| 000 | 01359 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513033608.0 | ||
| 264 | 0 | _c19950801 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a0362-1642 | ||
| 024 | 7 |
_a10.1146/annurev.pa.35.040195.000415 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarton, L J | |
| 245 | 0 | 0 |
_aPolyamines as targets for therapeutic intervention. _h[electronic resource] |
| 260 |
_bAnnual review of pharmacology and toxicology _c1995 |
||
| 300 |
_a55-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAdenosylmethionine Decarboxylase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDNA _xdrug effects |
| 650 | 0 | 4 |
_aEflornithine _xtherapeutic use |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 |
_aOrnithine Decarboxylase _xgenetics |
| 650 | 0 | 4 | _aOrnithine Decarboxylase Inhibitors |
| 650 | 0 | 4 |
_aParasitic Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aPolyamines _xantagonists & inhibitors |
| 700 | 1 | _aPegg, A E | |
| 773 | 0 |
_tAnnual review of pharmacology and toxicology _gvol. 35 _gp. 55-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1146/annurev.pa.35.040195.000415 _zAvailable from publisher's website |
| 999 |
_c7597946 _d7597946 |
||